We invite you to explore the links below to find out more about commercial litigation, intellectual property, mesothelioma cancer, pharmaceutical (drug) liability, product liability, toxic exposures and wrongful death!
|
Syndicate
Wall Street Journal: Health Blog
WSJ's blog on health and the business of health.
Updated: 23 min 2 sec ago
Sanofi-Aventis Sidles Up to Genzyme With ‘Informal Approach,’ WSJ Reports
Categories: NEWS: Health and Medical
A Wrap-Up From the International AIDS Conference in Vienna
Treatment as a means of curbing the epidemic, an end to the war on drugs and the need for funding were all on the agenda in Vienna this week.
Categories: NEWS: Health and Medical
A.M. Vitals: Gene Manipulation Improves Alzheimer’s Symptoms in Mice
Also: the mental toll of war on soldiers; five NYC hospitals trying "health courts"; minor league baseball players will be tested for HGH.
Categories: NEWS: Health and Medical
Will New Guidelines Let More Women Try Labor After a C-Section?
Actual medical practice is also driven by personal experience and professional liability concerns, but the guidelines should help.
Categories: NEWS: Health and Medical
A.M. Vitals: FDA Halts New Enrollment in Avandia-Actos Trial
Also: surpluses at nonprofit insurers; tainted heparin investigation; new rules on external review of denied insurance claims.
Categories: NEWS: Health and Medical
NEJM Study: Some ACL Tears May Not Need Quick Surgery
Which type of patient is more likely to benefit from quick surgery, and which from a wait-and-see approach?
Categories: NEWS: Health and Medical
American Council on Exercise: Study Finds Toning Shoes Don’t Work
A study by University of Wisconsin, La Crosse researchers doesn't find much to "toning shoe" claims.
Categories: NEWS: Health and Medical
A.M. Vitals: FDA Panel Votes to Strip Avastin’s Breast Cancer Indication
Also: Harvard Med School tightens its rules on faculty-industry involvement; WellPoint exec leaves; Chamber of Commerce sets up health-overhaul complaint site.
Categories: NEWS: Health and Medical
J&J’s 2010 Price Tag for Recalls: $600 Million. But What About Reputation?
J&J didn't venture a guess on how much the recalls could hurt its sales or earnings in 2011, or whether there would be residual damage.
Categories: NEWS: Health and Medical
A.M. Vitals: Avandia Panel Member a Paid Speaker for GSK
Also: hospitals using Tasers; cautious optimism over a possible HIV preventive; end of the line for swine flu pandemic?
Categories: NEWS: Health and Medical